Income Statement (TTM)
Kaleido Biosciences, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
|
|---|---|---|---|---|---|---|
| Revenue | 1 | 1 | 1 | 1 | 1 | 1 |
| Change (%) | 33.20 | 30.46 | -3.07 | -30.66 | 29.12 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 106 | 56 | 60 | 65 | 67 | 68 |
| Change (%) | -47.13 | 7.23 | 8.00 | 2.70 | 1.86 | |
| % of Revenue | 14,461.89 | 5,740.21 | 4,718.16 | 5,256.69 | 7,785.61 | 6,141.58 |
| Gross Operating Profit | -105 | -55 | -59 | -64 | -66 | -67 |
| Change (%) | -47.69 | 6.82 | 8.24 | 3.35 | 1.50 | |
| % of Revenue | -14,361.89 | -5,640.21 | -4,618.16 | -5,156.69 | -7,685.61 | -6,041.58 |
| SG&A | 24 | 24 | 23 | 24 | 22 | 21 |
| Change (%) | 1.36 | -1.91 | 0.96 | -8.86 | -2.73 | |
| % of Revenue | 3,218.72 | 2,449.44 | 1,841.59 | 1,918.17 | 2,521.17 | 1,899.28 |
| R&D | -50 | |||||
| Change (%) | ||||||
| % of Revenue | -6,850.41 | |||||
| OpEx | 79 | 80 | 83 | 88 | 88 | 89 |
| Change (%) | 0.96 | 4.25 | 6.02 | -0.39 | 0.57 | |
| % of Revenue | 10,830.19 | 8,209.44 | 6,559.75 | 7,174.86 | 10,306.78 | 8,027.72 |
| Operating Income | -79 | -79 | -82 | -87 | -87 | -88 |
| Change (%) | 0.66 | 3.92 | 6.16 | 0.04 | 0.29 | |
| % of Revenue | -10,730.19 | -8,109.44 | -6,459.75 | -7,074.86 | -10,206.78 | -7,927.72 |
| Interest Expense | -2 | -3 | -3 | -3 | -3 | -3 |
| Change (%) | 22.63 | 0.75 | 0.78 | -0.14 | -0.11 | |
| % of Revenue | -312.16 | -287.38 | -221.93 | -230.74 | -332.28 | -257.07 |
| Net Income | -81 | -82 | -85 | -90 | -90 | -90 |
| Change (%) | 0.62 | 4.28 | 5.84 | -0.05 | 0.28 | |
| % of Revenue | -11,081.42 | -8,371.28 | -6,691.12 | -7,305.60 | -10,530.06 | -8,178.26 |
Source: Capital IQ
